Delbridge, A R D
Grabow, S
Bouillet, P
Adams, J M
Strasser, A
Article History
Received: 25 January 2014
Revised: 7 March 2014
Accepted: 26 March 2014
First Online: 26 May 2014
Competing interests
: The authors are employed by The Walter and Eliza Hall Institute. The Walter and Eliza Hall Institute receives milestone payments from Genentech and AbbVie for the development of ABT-199 for cancer therapy.